
|Videos|April 18, 2022
Venetoclax in Combination with Daratumumab for Multiple Myeloma Treatment
Author(s)Shaji K. Kumar, MD, Jonathan L. Kaufman, MD
Sponsored in Part by AbbVie/Content Independently Developed by Targeted Oncology. A look at clinical trial efficacy data on daratumumab plus bortezomib and venetoclax for multiple myeloma treatment.
Episodes in this series






















